Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• Auto-reactive B lymphocytes and aberrant CD40 signaling are implicated in systemic lupus erythematosus (SLE) pathogenesis.
• CD40-CD154 interactions are crucial for B cell activation and immune responses.

Purpose of the Study:

• To investigate CD40 expression and CD40/CD154-induced NF-κB signaling pathway activation in B cells from SLE patients.
• To compare signaling in SLE B cells with controls from healthy volunteers and chronic tonsillitis.

Main Methods:

• Analysis of CD40 expression in B cells.
• Assessment of NF-κB signaling pathway components (IκBα, P65, P50, c-Rel) and kinase activities (IKKα/β).
• Use of anti-CD154, IκB phosphorylation inhibitors, and proteasome degradation inhibitors.

Main Results:

• Constitutive activation of CD40-induced NF-κB signaling was observed in B cells from active lupus patients.
• Decreased CD40 in rafts, increased IκBα phosphorylation/degradation, and P65 phosphorylation/nuclear translocation were noted in lupus B cells.
• CD154 stimulation further enhanced NF-κB activation, and CD40-induced kinase activities mimicked those in tonsil B cells.

Conclusions:

• Canonical NF-κB signaling is constitutively activated in active lupus B lymphocytes.
• This activation is mediated by CD154/CD40 interactions and differs from normal B cells.
• Targeting CD40/CD154 pathways may offer therapeutic strategies for SLE.